This is a copy of the June 3rd edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, New Cannabis Ventures, together with 420 Investor,...
MPX Raises US$40 Million Secured Convertible Loan To Fund Capacity Development of MPX Assets and Acquisitions TORONTO, ONTARIO, May 29, 2018 – MPX Bioceutical Corporation (“MPX” or the “Company”)...
Cannabis stocks, as measured by the Global Cannabis Stock Index, fell slightly in April, declining 0.5% to 107.33, after bouncing twice near 95 early in the month: The index, which went through...
MPX Signs a Letter of Intent to Acquire Canadian Licenced Producer Canveda TORONTO, April 17, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to...
TORONTO, April 09, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the official opening of the its newest “Health...
Mpx Enjoys Record Monthly Revenue of Cdn$5.2 Million in Arizona TORONTO, April 03, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) has reported that its managed...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter....
TORONTO, March 05, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to provide an operational and financial update to...
MPX Signs Definitive Agreement to Expand Its Footprint in Arizona TORONTO, March 05, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that...
MPX Reports Q3 Fiscal 2018 Results Execution of Expansion Strategy TORONTO, March 01, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Corporation” or “MPX”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its...
TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce its inclusion in the newly created Horizons Emerging Marijuana...
Following its highly successful initial ETF, Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (OTC: HMLSF), which boasts assets in excess of C$700 million, Canadian fund manager Horizons ETF...
Exclusive interview with MPX Bioceutical Corporation’s COO Elizabeth Stavola Elizabeth Stavola joined MPX Bioceutical Corporation (CSE: MPX) (OTC: MPXEF) last year. Formerly the Canadian Bioceutical Corporation, the company focuses...
MPX Enters Into Management and Option Agreement With Dispensary in Baltimore, Maryland TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is...
MPX Appoints New Chief Financial Officer TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren...
MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and Marketing of Pharma-Grade Cannabinoid Products TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company”...
MPX Enters Into Management and Option Agreements With Production Facility and Second Dispensary in Maryland One of only 14 Production Licenses Issued to Process Cannabis in the State of...
MPX Comments on Attorney General Jeff Sessions’s Memo re: Marijuana Enforcement TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) would like...
MPX Bioceutical Announces Beth Stavola Appointed to New Jersey Cannabis Industry Association Board of Trustees TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”)...
Amanda Chicago Lewis shared some interesting predictions in Rolling Stone on Friday, discussing marijuana lounges, a potential “bloodbath” in California, the end of characterizing strains as “indica” or “sativa” and...
MPX Closes Oversubscribed Private Placement Offering of $26.5 Million TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) — (CSE:MPX) (OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased...
Ohio’s Department of Commerce, which has already awarded Tier 1 and Tier 2 provisional cultivation licenses and named 370 dispensary applicants, announced today 104 applications for up to 40...
MPX Bioceutical Corporation Provides Update on Private Placement TORONTO, Dec. 19, 2017 (GLOBE NEWSWIRE) — MPX Bioceutical Corp. (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to provide this...
MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore Maryland TORONTO, Dec. 12, 2017 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or...
MPX Bioceutical Receives Both Municipal and State Approval for GreenMart of Nevada NLV License Transfer Gives MPX strong presence in a large and growing Las Vegas adult use market...
